Trina Health of Missouri Opens State’s First Artificial Pancreas Treatment Clinic
February 28 2017 - 7:04AM
Business Wire
Revolutionary
Treatment Can Slow, Halt, and/or Reverse Chronic Complications in
Types 1 and 2 Diabetes
Animo Health, Inc., d/b/a Trina Health of
Missouri, today opened its inaugural Trina Health
Artificial Pancreas Treatment® (APT) Clinic at 1585 Woodlake Dr.,
Suite 104, Chesterfield, Mo. It is the first of many clinics that
Animo Health plans to open throughout the state that feature the
Trina Health APT - the only patented, FDA approved, and clinically
proven treatment that can slow, halt, and/or reverse, in most
cases, the chronic complications in Type I and II diabetes.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170228005634/en/
Trina Health of Missouri now offers St.
Louis-area diabetes sufferers the proven, FDA-approved Artificial
Pancreas Treatment® to slow, stop and/or even reverse diabetes at
their new Chesterfield clinic. (Photo: Business Wire)
“Diabetes causes more annual deaths than breast cancer and AIDS
combined,” stated Mark Pound, CEO and president of Trina
Health of Missouri. “For many years one of the main focuses on
diabetes has been controlling blood sugar, which is a symptom of
the underlying problem of improper carbohydrate metabolism. The
Artificial Pancreas Treatment treats the problem, not the
symptom.”
Trina Health of Missouri’s clinically licensed staff --
comprised of an MD, NP, and LPN --provides individualized
treatments specifically designed and monitored to each patient’s
level of diabetic complications.
Each session consists of three one-hour treatments
coupled with metabolic evaluations for a total combined time of 3.5
to 4 hours. New patients are treated weekly until complications
improve at which time their treatment frequency can decrease to
once every two to three weeks. Treatments are covered by most
primary insurance plans including Medicare and the Veterans
Administration (VA).
The eight-chair, 1,674 sq. ft. facility treats two rotations (16
patients) per day. To make an appointment or receive more
information, call (314) 628-1607 or visit
www.trinahealthofmo.com.
To celebrate the grand opening, Trina Health of Missouri will
host an Open House tonight from 5:00 to 8:00pm at 1585 Woodlake
Drive, Ste. 104, Chesterfield, MO 63017.
The Core Problem
In non-diabetics, the pancreas secretes bursts of insulin every
four to six minutes at a specific pressure to signal the liver to
produce enzymes necessary for proper carbohydrate metabolism.
Diabetes occurs when this metabolic communication breaks down and
the liver no longer receives its signals to function properly. This
results in oxidative stress and inflammation leading to diabetic
complications such as neuropathy, retinopathy, nephropathy,
cardiovascular disease, fatigue, erectile dysfunction, and
death.
Artificial Pancreas Treatment (APT)
APT is the only process that promotes normalization of
carbohydrate metabolism in diabetic patients to slow, halt, and/or
reverse the chronic complications in Type 1 and Type 2 diabetes.
Patient comfort is optimized as they’re able to walk and/or sit
while wearing the patented, FDA-approved Bionica Microdose Pump.
About the size of a large smart phone, this mobile device uses IV
infusion to mimic the insulin pulses of a healthy pancreas. This in
turn stimulates the liver to produce the enzymes necessary for
carbohydrate metabolism, which lowers lipid metabolism, resulting
in more cellular energy in body tissues. APT also calms
inflammatory cytokines, reduces cellular oxygen requirements, helps
normalize blood flow and allows cells and organs to heal themselves
throughout the body.
However, the Artificial Pancreas Treatment is not a cure.
“Doctors and patients ask if Trina Health APT is so wonderful,
how come they’ve never heard of it,” said Chris LaBelle, chief
business development officer for Trina Health of Missouri. “It took
the inventor, G. Ford Gilbert, JD, PhD, 27 years of
development, 16 university clinical trials and over 53 publications
to develop the device and establish consistent treatment
protocols.”
About Trina Health, LLC, in Partnership with Animo Health,
Inc.
With over 200,000 treatments with no adverse reactions and more
than 24 domestic and international clinics, the Trina Health
Artificial Pancreas Treatment is expanding throughout the United
States and abroad. Animo Health, Inc. doing business as Trina
Health of Missouri, has obtained exclusive rights to establish
clinics throughout Missouri and the Midwest using Trina Health’s
Artificial Pancreas Treatment that can slow, halt, and/or reverse
in most cases the chronic complications in Type 1 and Type 2
diabetes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170228005634/en/
Daly-Swartz PR for Trina Health of MissouriJeffrey Swartz,
949-470-0075jeffreyswartz@dsprel.com